"The future of in vitro toxicology"

Toxicology in Vitro

Volumn 29, Issue 6, 2015, Pages 1217-1221

  Jennings, Paul ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

3R; IPSC; Omics; Stem cells

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BIOLOGICAL MARKER; CELL NUCLEUS RECEPTOR; CYCLOSPORIN A; CYTOCHROME P450; HALOGENATED HYDROCARBON; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 13; INTERLEUKIN 19; POLYCYCLIC AROMATIC HYDROCARBON; TELOMERASE; TRANSCRIPTION FACTOR NRF2;

ADVERSE OUTCOME; BIOENGINEERING; CASPASE ASSAY; CONCENTRATION (PARAMETERS); CONTACT INHIBITION; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; ENZYME SPECIFICITY; EPIGENETICS; EXTRACELLULAR MATRIX; GENETIC DRIFT; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IL 19 GENE; IMMORTALIZED CELL LINE; IN VITRO STUDY; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; LD50; LIVER TOXICITY; METABOLOMICS; MICROFLUIDICS; MTT ASSAY; MUTATIONAL ANALYSIS; NONHUMAN; OXIDATIVE STRESS; OXYGEN SATURATION; PLURIPOTENT STEM CELL; PREDICTION; PRIMARY CELL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; RESAZURIN ASSAY; REVIEW; RISK ASSESSMENT; TOXICOLOGY; TRANSCRIPTOMICS; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE; XENOBIOTIC METABOLISM; ANIMAL; PROCEDURES; TOXICITY TESTING;

ANIMALIA; MAMMALIA;

ANIMALS; HUMANS; IN VITRO TECHNIQUES; TOXICITY TESTS;

EID: 84930761289     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.08.011     Document Type: Review

References (21)

1. Aschauer L., Gruber L.N., Pfaller W., Limonciel A., Athersuch T.J., Cavill R., Khan A., Gstraunthaler G., Grillari J., Grillari R., Hewitt P., Leonard M.O., Wilmes A., Jennings P. Delineation of the key aspects in the regulation of epithelial monolayer formation. Mol. Cell Biol. 2013, 33:2535-2550.
2. Balmer N.V., Dao T., Leist M., Vojnits K., Waldmann T., Zhao L., Hogberg H.T., Vliet E. Application of "Omics" technologies to in vitro toxicology. Vitro Toxicol. Syst. 2014, 399-432.
3. Corren J., Lemanske R.F., Hanania N.A., Korenblat P.E., Parsey M.V., Arron J.R., Harris J.M., Scheerens H., Wu L.C., Su Z., Mosesova S., Eisner M.D., Bohen S.P., Matthews J.G. Lebrikizumab treatment in adults with asthma. N Engl. J. Med. 2011, 365:1088-1098.
4. Denison M.S., Soshilov A.A., He G., DeGroot D.E., Zhao B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 2011, 124:1-22.
5. Fratta I.D., Sigg E.B., Maiorana K. Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice. Toxicol. Appl. Pharmacol. 1965, 7:268-286.
6. Hu Y.F., Qiu W., Liu Z.Q., Zhu L.J., Liu Z.Q., Tu J.H., Wang D., Li Z., He J., Zhong G.P., Zhou G., Zhou H.H. Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. Clin. Exp. Pharmacol. Physiol. 2006, 33:1093-1098.
7. Jennings P. Stress response pathways, toxicity pathways and adverse outcome pathways. Arch. Toxicol. 2013, 87:13-14.
8. Jennings P., Crean D., Aschauer L., Limonciel A., Moenks K., Kern G., Hewitt P., Lhotta K., Lukas A., Wilmes A., Leonard M.O. Interleukin-19 as a translational indicator of renal injury. Arch. Toxicol. 2014.
9. Kim J.H., Scialli A.R. Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol. Sci. 2011, 122:1-6.
10. Leonard M.O., Limonciel A., Jennings P. Stress Response Pathways, In Vitro Toxicology Systems 2014, Springer, New York, pp. 433-458.
11. Limonciel, A., 2014. The past, present, and future of chemical risk assessment. T In Vitro Toxicology Systems, pp. 3-23.
12. Monteforte N., Priori S.G. The long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. Pacing Clin. Electrophysiol. 2009, 32(Suppl. 2):S52-S57.
13. Rauch C., Jennings P., Wilmes A. Use of Induced Pluripotent Stem Cells in Drug Toxicity Screening, In Vitro Toxicology Systems 2014, Springer, New York, pp. 335-350.
14. Russell W.M.S., Burch R.L. The Principles of Humane Experimental Technique 1959, Methuen.
15. Wieser M., Stadler G., Jennings P., Streubel B., Pfaller W., Ambros P., Riedl C., Katinger H., Grillari J., Grillari-Voglauer R. HTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am. J. Physiol. Renal Physiol. 2008, 295:F1365-F1375.
16. Wilmes A., Crean D., Aydin S., Pfaller W., Jennings P., Leonard M.O. Identification and dissection of the Nrf2 mediated oxidative stress pathway in human renal proximal tubule toxicity. Toxicol. In Vitro 2011, 25:613-622.
17. Wilmes A., Limonciel A., Aschauer L., Moenks K., Bielow C., Leonard M.O., Hamon J., Carpi D., Ruzek S., Handler A., Schmal O., Herrgen K., Bellwon P., Burek C., Truisi G.L., Hewitt P., Di Consiglio E., Testai E., Blaauboer B.J., Guillou C., Huber C.G., Lukas A., Pfaller W., Mueller S.O., Bois F.Y., Dekant W., Jennings P. Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J. Proteomics 2013, 79:180-194.
18. Wilmes A., Aschauer L., Limonciel A., Pfaller W., Jennings P. Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol. Appl. Pharmacol. 2014, 279:163-172.
19. Wilmes A., Limonciel A., Leonard M., Jennings P. Translational biomarkers, in vitro and in vivo. In Vitro Toxicology Systems 2014, 459-478. Springer, New York. A. Bal-Price, P. Jennings (Eds.).
20. Woodruff P.G., Boushey H.A., Dolganov G.M., Barker C.S., Yang Y.H., Donnelly S., Ellwanger A., Sidhu S.S., Dao-Pick T.P., Pantoja C., Erle D.J., Yamamoto K.R., Fahy J.V. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. USA 2007, 104:15858-15863.
21. Zager R.A., Johnson A.C., Becker K. Plasma and urinary heme oxygenase-1 in AKI. J. Am. Soc. Nephrol. 2012, 23:1048-1057.